NT Pharma Canada

NT Pharma Canada Inc. is a specialty pharmaceutical company headquartered in Montreal, Quebec, and operates as a subsidiary of the China NT Pharma Group. The company is dedicated to the commercialization, distribution, and regulatory oversight of specialty medicines within the Canadian market, with a particular focus on bone health and endocrinology. Its primary product is Miacalcic (calcitonin salmon), a therapeutic used for the treatment of postmenopausal osteoporosis, Paget's disease of bone, and hypercalcemia. NT Pharma Canada manages the entire lifecycle of its products in Canada, including Health Canada compliance, quality assurance, and supply chain logistics. The company serves as a strategic hub for its parent organization's expansion into the North American pharmaceutical landscape.